Disrupting the PCSK9/LDLR protein-protein interaction by an imidazole-based minimalist peptidomimetic.
暂无分享,去创建一个
Carmen Lammi | Giovanni Grazioso | Silvia Manara | Giordano Lesma | Alessandra Silvani | C. Lammi | A. Arnoldi | Silvia Manara | C. Zanoni | G. Grazioso | M. Stucchi | G. Lesma | A. Silvani | Anna Arnoldi | Chiara Zanoni | Mattia Stucchi
[1] Jean-Luc Poyet,et al. Drug-Like Protein–Protein Interaction Modulators: Challenges and Opportunities for Drug Discovery and Chemical Biology , 2014, Molecular informatics.
[2] A. Hamilton,et al. A Modular Synthesis of Conformationally Preorganised Extended β-Strand Peptidomimetics. , 2015, Chemistry.
[3] A. Iskandrian,et al. Major risk factors for cardiovascular disease: debunking the "only 50%" myth. , 2003, JAMA.
[4] Erinna F. Lee,et al. Evaluation of diverse α/β-backbone patterns for functional α-helix mimicry: analogues of the Bim BH3 domain. , 2012, Journal of the American Chemical Society.
[5] Pauline N. Wyrembak,et al. Alkyne-linked 2,2-disubstituted-indolin-3-one oligomers as extended beta-strand mimetics. , 2009, Journal of the American Chemical Society.
[6] G. Verdine,et al. Stapled peptides for intracellular drug targets. , 2012, Methods in enzymology.
[7] Hyun Pyo Kim,et al. 1,5-Diarylimidazoles with strong inhibitory activity against COX-2 catalyzed PGE2 production from LPS-induced RAW 264.7 cells. , 2010, Bioorganic & medicinal chemistry letters.
[8] K Schulten,et al. VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.
[9] Kevin Burgess,et al. Minimalist and universal peptidomimetics. , 2011, Chemical Society reviews.
[10] J. D. Del Valle,et al. Substituted imidazo[1,2-a]pyridines as β-strand peptidomimetics. , 2012, Organic letters.
[11] Nathan T. Ross,et al. Synthetic mimetics of protein secondary structure domains , 2010, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.
[12] C. Lammi,et al. Lupin Peptides Modulate the Protein-Protein Interaction of PCSK9 with the Low Density Lipoprotein Receptor in HepG2 Cells , 2016, Scientific Reports.
[13] A. Hamilton,et al. A 1,3-phenyl-linked hydantoin oligomer scaffold as a β-strand mimetic. , 2012, Chemical communications.
[14] Pedro A Fernandes,et al. Hot spots—A review of the protein–protein interface determinant amino‐acid residues , 2007, Proteins.
[15] S. Jones,et al. Principles of protein-protein interactions. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[16] Kim D Janda,et al. Protein-protein interactions and cancer: targeting the central dogma. , 2011, Current topics in medicinal chemistry.
[17] Ralph Hirschmann,et al. Design, synthesis, and crystal structure of a pyrrolinone-based peptidomimetic possessing the conformation of a .beta.-strand: potential application to the design of novel inhibitors of proteolytic enzymes , 1992 .
[18] Wei Li,et al. Identification of a Small Peptide That Inhibits PCSK9 Protein Binding to the Low Density Lipoprotein Receptor , 2013, The Journal of Biological Chemistry.
[19] D. Fairlie,et al. Beta-strand mimetics. , 2004, Chemical reviews.
[20] E. Gillies,et al. Amphipathic beta-strand mimics as potential membrane disruptive antibiotics. , 2009, The Journal of organic chemistry.
[21] Lamberth Clemens,et al. チュブリン重合促進因子の合成と真菌殺傷活性 パート3:イミダゾール類 | 文献情報 | J-GLOBAL 科学技術総合リンクセンター , 2013 .
[22] Ralph Hirschmann,et al. De Novo Design, Synthesis, and X-ray Crystal Structures of Pyrrolinone-Based .beta.-Strand Peptidomimetics , 1994 .
[23] Jonathan C. Cohen,et al. Binding of Proprotein Convertase Subtilisin/Kexin Type 9 to Epidermal Growth Factor-like Repeat A of Low Density Lipoprotein Receptor Decreases Receptor Recycling and Increases Degradation* , 2007, Journal of Biological Chemistry.
[24] W. Hiatt,et al. Reducing LDL with PCSK9 Inhibitors--The Clinical Benefit of Lipid Drugs. , 2015, The New England journal of medicine.
[25] P. Arora,et al. Nonpeptidic foldamers from amino acids: synthesis and characterization of 1,3-substituted triazole oligomers. , 2005, Journal of the American Chemical Society.
[26] A. Hamilton,et al. β-Strand mimetic foldamers rigidified through dipolar repulsion. , 2015, Angewandte Chemie.
[27] A. Hamilton,et al. Aryl-linked imidazolidin-2-ones as non-peptidic β-strand mimetics. , 2012, Chemical communications.
[28] J. Wildeman,et al. Chemistry of sulfonylmethyl isocyanides. 12. Base-induced cycloaddition of sulfonylmethyl isocyanides to carbon,nitrogen double bonds. Synthesis of 1,5-disubstituted and 1,4,5-trisubstituted imidazoles from aldimines and imidoyl chlorides , 1977 .
[29] E. Settembre,et al. Mechanistic implications for LDL receptor degradation from the PCSK9/LDLR structure at neutral pH , 2011, EMBO reports.
[30] R. Krauss,et al. Proprotein convertase subtilisin/kexin type 9 inhibition: a new therapeutic mechanism for reducing cardiovascular disease risk. , 2015, Circulation.
[31] D. Fairlie,et al. Update 1 of: Beta-strand mimetics. , 2010, Chemical reviews.
[32] A. Hamilton,et al. Disrupting protein-protein interactions with non-peptidic, small molecule alpha-helix mimetics. , 2010, Current opinion in chemical biology.
[33] Wendell A. Lim,et al. β Strand Peptidomimetics as Potent PDZ Domain Ligands , 2006 .
[34] R. Hirschmann,et al. Pyrrolinone-based peptidomimetics. "Let the enzyme or receptor be the judge". , 2011, Accounts of chemical research.
[35] S. Chandrasekhar,et al. Oligomers of cis-β-norbornene amino acid: Formation of β-strand mimetics , 2006 .
[36] P. Bartlett,et al. Synthesis of amino acid-derived cyclic acyl amidines for use in beta-strand peptidomimetics. , 2007, The Journal of organic chemistry.
[37] D. Fairlie,et al. Downsizing human, bacterial, and viral proteins to short water-stable alpha helices that maintain biological potency , 2010, Proceedings of the National Academy of Sciences.
[38] Andrew J. Wilson,et al. Inhibition of α-helix-mediated protein-protein interactions using designed molecules. , 2013, Nature chemistry.
[39] R. Cetin-Atalay,et al. Application of the Ugi reaction with multiple amino acid-derived components: synthesis and conformational evaluation of piperazine-based minimalist peptidomimetics. , 2015, Organic & biomolecular chemistry.
[40] Jerome Wielens,et al. Oncogenic protein interfaces: small molecules, big challenges , 2014, Nature Reviews Cancer.
[41] Annik Prat,et al. The biology and therapeutic targeting of the proprotein convertases , 2012, Nature Reviews Drug Discovery.
[42] T. Ioerger,et al. Pyrrolinone-pyrrolidine oligomers as universal peptidomimetics. , 2011, Journal of the American Chemical Society.
[43] Junmei Wang,et al. Development and testing of a general amber force field , 2004, J. Comput. Chem..
[44] S. Steinhubl,et al. New Drugs and Technologies , 2014 .
[45] Gabriel Waksman,et al. Protein–protein interaction through β-strand addition , 2006 .
[46] D. Fairlie,et al. Constraining cyclic peptides to mimic protein structure motifs. , 2014, Angewandte Chemie.